 | • レポートコード：GIR201109454 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、T細胞表面糖タンパク質CD3イプシロン鎖の世界市場を調査対象にし、T細胞表面糖タンパク質CD3イプシロン鎖の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他）、用途別分析（自己免疫疾患、B型肝炎、多発性硬化症、前立腺癌、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amgen Inc、SYNIMMUNE GmbH、GlaxoSmithKline Plc、Celgene Corp、Numab Innovation AG、F. Hoffmann-La Roche Ltd、Meridigen Biotech Co Ltd、MacroGenics Inc、Tiziana Life Sciences Plc ・メーカー別販売量、売上、市場シェア ・T細胞表面糖タンパク質CD3イプシロン鎖の地域別市場分析 ・T細胞表面糖タンパク質CD3イプシロン鎖の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・T細胞表面糖タンパク質CD3イプシロン鎖のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・T細胞表面糖タンパク質CD3イプシロン鎖のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・T細胞表面糖タンパク質CD3イプシロン鎖の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・T細胞表面糖タンパク質CD3イプシロン鎖の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・T細胞表面糖タンパク質CD3イプシロン鎖の種類別市場規模2015-2020：ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他 ・T細胞表面糖タンパク質CD3イプシロン鎖の用途別市場規模2015-2020：自己免疫疾患、B型肝炎、多発性硬化症、前立腺癌、その他 ・T細胞表面糖タンパク質CD3イプシロン鎖の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global T Cell Surface Glycoprotein CD3 Epsilon Chain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The T Cell Surface Glycoprotein CD3 Epsilon Chain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
T Cell Surface Glycoprotein CD3 Epsilon Chain market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, T Cell Surface Glycoprotein CD3 Epsilon Chain market has been segmented into
ND-007
Foralumab
Coltelizumab
AVA-002
Others
By Application, T Cell Surface Glycoprotein CD3 Epsilon Chain has been segmented into:
Autoimmune Disorders
Hepatitis B
Multiple Sclerosis
Prostate Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global T Cell Surface Glycoprotein CD3 Epsilon Chain market presented in the report. This section sheds light on the sales growth of different regional and country-level T Cell Surface Glycoprotein CD3 Epsilon Chain markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global T Cell Surface Glycoprotein CD3 Epsilon Chain market.
The report offers in-depth assessment of the growth and other aspects of the T Cell Surface Glycoprotein CD3 Epsilon Chain market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Analysis
T Cell Surface Glycoprotein CD3 Epsilon Chain competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, T Cell Surface Glycoprotein CD3 Epsilon Chain sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the T Cell Surface Glycoprotein CD3 Epsilon Chain sales, revenue and market share for each player covered in this report.
The major players covered in T Cell Surface Glycoprotein CD3 Epsilon Chain are:
Amgen Inc
SYNIMMUNE GmbH
GlaxoSmithKline Plc
Celgene Corp
Numab Innovation AG
F. Hoffmann-La Roche Ltd
Meridigen Biotech Co Ltd
MacroGenics Inc
Tiziana Life Sciences Plc
Among other players domestic and global, T Cell Surface Glycoprotein CD3 Epsilon Chain market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe T Cell Surface Glycoprotein CD3 Epsilon Chain product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of T Cell Surface Glycoprotein CD3 Epsilon Chain, with price, sales, revenue and global market share of T Cell Surface Glycoprotein CD3 Epsilon Chain in 2018 and 2019.
Chapter 3, the T Cell Surface Glycoprotein CD3 Epsilon Chain competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the T Cell Surface Glycoprotein CD3 Epsilon Chain breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, T Cell Surface Glycoprotein CD3 Epsilon Chain market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe T Cell Surface Glycoprotein CD3 Epsilon Chain sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ND-007
1.2.3 Foralumab
1.2.4 Coltelizumab
1.2.5 AVA-002
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Autoimmune Disorders
1.3.3 Hepatitis B
1.3.4 Multiple Sclerosis
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Overview of Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market
1.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen Inc SWOT Analysis
2.1.4 Amgen Inc Product and Services
2.1.5 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 SYNIMMUNE GmbH
2.2.1 SYNIMMUNE GmbH Details
2.2.2 SYNIMMUNE GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SYNIMMUNE GmbH SWOT Analysis
2.2.4 SYNIMMUNE GmbH Product and Services
2.2.5 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline Plc SWOT Analysis
2.3.4 GlaxoSmithKline Plc Product and Services
2.3.5 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene Corp
2.4.1 Celgene Corp Details
2.4.2 Celgene Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celgene Corp SWOT Analysis
2.4.4 Celgene Corp Product and Services
2.4.5 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Numab Innovation AG
2.5.1 Numab Innovation AG Details
2.5.2 Numab Innovation AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Numab Innovation AG SWOT Analysis
2.5.4 Numab Innovation AG Product and Services
2.5.5 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche Ltd
2.6.1 F. Hoffmann-La Roche Ltd Details
2.6.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.6.4 F. Hoffmann-La Roche Ltd Product and Services
2.6.5 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Meridigen Biotech Co Ltd
2.7.1 Meridigen Biotech Co Ltd Details
2.7.2 Meridigen Biotech Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Meridigen Biotech Co Ltd SWOT Analysis
2.7.4 Meridigen Biotech Co Ltd Product and Services
2.7.5 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 MacroGenics Inc
2.8.1 MacroGenics Inc Details
2.8.2 MacroGenics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MacroGenics Inc SWOT Analysis
2.8.4 MacroGenics Inc Product and Services
2.8.5 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Tiziana Life Sciences Plc
2.9.1 Tiziana Life Sciences Plc Details
2.9.2 Tiziana Life Sciences Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Tiziana Life Sciences Plc SWOT Analysis
2.9.4 Tiziana Life Sciences Plc Product and Services
2.9.5 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Manufacturer (2018-2019)
3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturer Market Share in 2019
3.3.2 Top 6 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Market Share by Regions
4.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Regions (2015-2020)
4.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Regions (2015-2020)
4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
4.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
4.5 South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Market Share by Country
5.1.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Country (2015-2020)
5.1.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Country (2015-2020)
5.2 United States T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
5.3 Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
5.4 Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Market Share by Country
6.1.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Country (2015-2020)
6.1.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Country (2015-2020)
6.2 Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
6.3 UK T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
6.4 France T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
6.5 Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
6.6 Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Regions (2015-2020)
7.2 China T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
7.3 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
7.4 Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
7.5 India T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
7.6 Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
7.7 Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Market Share by Country
8.1.1 South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Country (2015-2020)
8.1.2 South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Country (2015-2020)
8.2 Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
8.3 Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
9.3 Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
9.4 Egypt T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
9.5 South Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Market Share by Type (2015-2020)
10.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Market Share by Type (2015-2020)
10.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price by Type (2015-2020)
11 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Segment by Application
11.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application (2015-2020)
11.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2015-2020)
11.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price by Application (2015-2020)
12 Market Forecast
12.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Revenue and Growth Rate (2021-2025)
12.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast by Regions (2021-2025)
12.2.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025)
12.2.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025)
12.2.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025)
12.2.4 South America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025)
12.2.5 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025)
12.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast by Type (2021-2025)
12.3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Type (2021-2025)
12.3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Forecast by Type (2021-2025)
12.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast by Application (2021-2025)
12.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Application (2021-2025)
12.4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of T Cell Surface Glycoprotein CD3 Epsilon Chain by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 9. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 10. Amgen Inc SWOT Analysis
Table 11. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 12. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. SYNIMMUNE GmbH Basic Information, Manufacturing Base and Competitors
Table 14. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 15. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 16. SYNIMMUNE GmbH SWOT Analysis
Table 17. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 18. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 21. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 22. GlaxoSmithKline Plc SWOT Analysis
Table 23. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 24. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Celgene Corp Basic Information, Manufacturing Base and Competitors
Table 26. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 27. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 28. Celgene Corp SWOT Analysis
Table 29. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 30. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Numab Innovation AG Basic Information, Manufacturing Base and Competitors
Table 32. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 33. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 34. Numab Innovation AG SWOT Analysis
Table 35. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 36. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 38. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 39. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 40. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 41. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 42. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Meridigen Biotech Co Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 45. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 46. Meridigen Biotech Co Ltd SWOT Analysis
Table 47. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 48. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. MacroGenics Inc Basic Information, Manufacturing Base and Competitors
Table 50. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 51. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 52. MacroGenics Inc SWOT Analysis
Table 53. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 54. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Tiziana Life Sciences Plc Basic Information, Manufacturing Base and Competitors
Table 56. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Major Business
Table 57. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Total Revenue (USD Million) (2018-2019)
Table 58. Tiziana Life Sciences Plc SWOT Analysis
Table 59. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product and Services
Table 60. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Regions (2015-2020) (K Pcs)
Table 64. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Regions (2015-2020)
Table 65. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Regions (2015-2020) (USD Million)
Table 66. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Countries (2015-2020) (K Pcs)
Table 67. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries (2015-2020)
Table 68. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Countries (2015-2020) (USD Million)
Table 69. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries (2015-2020)
Table 70. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries (2015-2020)
Table 72. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Regions (2015-2020) (USD Million)
Table 76. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Countries (2015-2020) (K Pcs)
Table 77. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries (2015-2020)
Table 78. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Countries (2015-2020) (USD Million)
Table 79. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries (2015-2020)
Table 84. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Type (2015-2020) (K Pcs)
Table 85. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Share by Type (2015-2020)
Table 86. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Type (2015-2020) (USD Million)
Table 87. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Type (2015-2020)
Table 88. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales by Application (2015-2020) (K Pcs)
Table 89. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Share by Application (2015-2020)
Table 90. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Forecast by Regions (2021-2025)
Table 92. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Forecast by Type (2021-2025)
Table 94. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Forecast by Application (2021-2025)
Table 95. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. T Cell Surface Glycoprotein CD3 Epsilon Chain Picture
Figure 2. Global Sales Market Share of T Cell Surface Glycoprotein CD3 Epsilon Chain by Type in 2019
Figure 3. ND-007 Picture
Figure 4. Foralumab Picture
Figure 5. Coltelizumab Picture
Figure 6. AVA-002 Picture
Figure 7. Others Picture
Figure 8. T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Application in 2018
Figure 9. Autoimmune Disorders Picture
Figure 10. Hepatitis B Picture
Figure 11. Multiple Sclerosis Picture
Figure 12. Prostate Cancer Picture
Figure 13. Others Picture
Figure 14. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Manufacturer in 2019
Figure 35. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Regions (2015-2020)
Figure 42. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Regions in 2018
Figure 43. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
Figure 44. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
Figure 46. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020)
Figure 48. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries (2015-2020)
Figure 50. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries in 2018
Figure 51. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries in 2018
Figure 53. United States T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries (2015-2020)
Figure 58. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries in 2019
Figure 59. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Regions 2019
Figure 66. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Regions 2019
Figure 67. China T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries in 2019
Figure 74. South America T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries in 2019
Figure 75. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
T細胞特異的表面糖タンパク質CD28の世界市場 2020年 Market Overview The global T Cell Specific Surface Glycoprotein CD28 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The T C…- 呼吸器合胞体ウイルス付着糖タンパク質の世界市場 2020年 Market Overview The global Respiratory Syncytial Virus Attachment Glycoprotein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- スノーチェーンの世界市場 2020年 Market Overview The Snow Chain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 表面保護テープの世界市場 2020年 Market Overview The Surface Protection Tape market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 中鎖トリグリセリド（MCT）の世界市場 2020年 Market Overview The Medium-chain Triglycerides (MCT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…